Pharmaceuticals: Why ad spending’s ailing
March 28, 2013
A number of ad categories have increased spending over the past few years following deep declines during the height of the recession.
Pharmaceuticals is not one of them.
Even as positive economic news builds, including a decrease in the unemployment rate, an increase in home building starts and a surge in the stock market, drug companies have reigned in their ad budgets.
Unlike many other categories, such as automotive and retail, pharmaceutical spending is tied not so much to the economy as to the state of the industry itself, and right now the mood is one of extreme caution.
Last year GlaxoKlineSmith reached a $3 billion settlement with the Justice Department over the marketing and development of its drugs. The government accused the British company of, among other things, advertising its drugs to treat ailments they were not approved for.
“Overall the business in the past several years has taken a more cautious approach to marketing in response to fears about regulation,” notes Jon Swallen, chief research officer at Kantar Media North America.
No one wants to be the next GlaxoKlineSmith, and in response many companies have pulled back on their advertising.
Last year spending in the category declined 3.8 percent, according to data crunched by Kantar and Nomura, from $7.6 billion to $7.31 billion.
It was the third-biggest decline for any top-20 ad category, behind only office supplies (down 10.3 percent) and media and entertainment (down 4.2 percent).
No individual pharmaceutical advertiser finished among the top 10 for 2012, according to Kantar. Pfizer was among the top seven until 2011.
Pharmaceutical advertising has dropped sharply in magazines as well as spot television, where spending plunged 30 percent last year, according to the TVB.
The other issue holding back spending is that there hasn’t been a major new drug introduction in some years. With no major new drugs to promote, pharmaceutical companies have little reason to increase spending.
In the past, rollouts of drugs such as Viagra, Lipitor and Zoloft have triggered a huge amount of ad spending to familiarize the public with the purpose and benefits of the new medications.
“Part of the reason is there have not been any big blockbuster marketing launches for newly approved drugs,” Swallen says.
“That was traditionally the catalyst during the last half of the past decade, 2005 to 2010. The category was propelled by marketing introductions.”
And with no major introductions on the horizon, the pharmaceutical ad chill could last for years to come.
The latest: Bloomberg Pursuits folds print edition
Victoria’s Secret sashays to No. 1 on Monday night
Orlando is the best city to party in on New Year’s Eve
Dallas Cowboys’ latest win tops social media
Five ad spending trends to watch for next year
Pondering the future of troubled Pandora (cont’d.)
Here are the top cable channels among Millennials
Back from the dead, yes, it’s Paste magazine
Introducing Media Life’s Out of Home Premium
Honoring Jimmy V with good early-season matchups
Time’s up: The Apple Watch appears to be tanking.
‘This Is Us’ rises to broadcast’s top L+3 drama
The worldwide leader in ad blocking: Poland
- Robert Arrindell becomes programmatic director at Rouge Media
- Mark Andersen becomes group creative director at Colle+McVoy
- Stephen Mooallem becomes editor in chief at The Village Voice
- Bruce Perlmutter becomes SVP of production at Condé Nast Entertainment
- Julia Ioffe becomes foreign policy reporter at The Atlantic
- Yoel Flohr becomes SVP of franchise development at AMC
- Dorothy Crompton becomes VP of format licensing at Fox TV Distribution
- Steve Dennen becomes head of partnerships at Simmons Research
- Nick McCarthy becomes UK and EMEA managing director at Signal
- Alexandra Breckenridge joins NBC's 'This Is Us'
- Jimmy Kimmel hosting ABC's Academy Awards
This week’s top-rated movies, songs and books
This week’s daypart ratings
This week’s broadcast ratings
This week’s cable ratings
This month’s digital traffic data: August 2016
This month’s new media traffic data
SEO and SEM manager opening in Pittsburgh
Media supervisor opening in New York
Media buyer/planner position in Madison, WI
Cincinnati agency needs a senior media strategist (online)
Senior media buyer position in San Diego